Tsfg, LLC’s Abbott Laboratories Position
Does Tsfg, LLC own Abbott Laboratories (ABT)? Yes — 113.3K shares worth $12M (+1.76% of its 13F portfolio) as of Q1 2026, down from 116.5K shares the prior filed quarter.
Position Value
$12M
Q1 2026
Shares
113.3K
% of Portfolio
+1.76%
Quarters Held
26
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 113.3K | $12M | +1.76% |
| Q4 2025 | 116.5K | $15M | +2.18% |
| Q3 2025 | 114.0K | $15M | +2.43% |
| Q2 2025 | 107.3K | $15M | +2.64% |
| Q1 2025 | 103.8K | $14M | +2.82% |
| Q4 2024 | 106.1K | $12M | +2.46% |
| Q3 2024 | 94.2K | $11M | +2.35% |
| Q2 2024 | 96.0K | $10M | +2.33% |
| Q1 2024 | 90.2K | $10M | +2.59% |
| Q4 2023 | 99.2K | $11M | +3.44% |
| Q3 2023 | 96.2K | $9M | +3.32% |
| Q2 2023 | 91.5K | $10M | +3.72% |
| Q1 2023 | 92.8K | $9M | +3.48% |
| Q4 2022 | 91.4K | $10M | +3.99% |
| Q3 2022 | 89.0K | $9M | +4.03% |
| Q2 2022 | 83.8K | $9M | +3.91% |
| Q1 2022 | 84.1K | $10M | +3.60% |
| Q4 2021 | 85.3K | $12M | +4.18% |
| Q3 2021 | 77.5K | $9M | +3.57% |
| Q2 2021 | 74.6K | $9M | +3.48% |
| Q1 2021 | 72.0K | $9M | +4.38% |
| Q4 2020 | 70.1K | $8M | +4.10% |
| Q3 2020 | 70.1K | $8M | +4.53% |
| Q2 2020 | 51.6K | $5M | +3.11% |
| Q1 2020 | 47.3K | $4M | +3.33% |
| Q4 2019 | 42.7K | $4M | +2.75% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tsfg, LLC’s full portfolio or all institutional holders of ABT.